Molina Healthcare, Inc. (NYSE:MOH) Shares Bought by Bleakley Financial Group LLC

Bleakley Financial Group LLC boosted its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 26.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 888 shares of the company’s stock after buying an additional 183 shares during the quarter. Bleakley Financial Group LLC’s holdings in Molina Healthcare were worth $306,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MOH. Innealta Capital LLC acquired a new stake in shares of Molina Healthcare in the second quarter valued at about $36,000. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Molina Healthcare in the second quarter valued at about $40,000. AM Squared Ltd acquired a new stake in shares of Molina Healthcare in the second quarter valued at about $59,000. UMB Bank n.a. grew its position in shares of Molina Healthcare by 96.2% in the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock valued at $71,000 after purchasing an additional 101 shares during the period. Finally, Fidelis Capital Partners LLC acquired a new stake in shares of Molina Healthcare in the first quarter valued at about $151,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

MOH has been the topic of a number of recent research reports. JPMorgan Chase & Co. lowered their price target on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 10th. Cantor Fitzgerald restated an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research report on Tuesday, October 1st. Truist Financial lowered their price target on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. Stephens restated an “equal weight” rating and set a $320.00 price target on shares of Molina Healthcare in a research report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a research report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $378.00.

Insider Activity

In other news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the sale, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Molina Healthcare Price Performance

Shares of MOH stock opened at $274.73 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The firm’s 50-day moving average is $336.17 and its two-hundred day moving average is $330.51. Molina Healthcare, Inc. has a 12 month low of $272.69 and a 12 month high of $423.92. The company has a market capitalization of $16.10 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 1.15 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. The business had revenue of $9.88 billion for the quarter, compared to the consensus estimate of $9.75 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business’s revenue was up 18.7% on a year-over-year basis. During the same period in the previous year, the firm earned $5.65 EPS. Analysts predict that Molina Healthcare, Inc. will post 23.5 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.